# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ:NXGL), a leading provider of medical and over-the-counter (OTC...
Citigroup analyst Leo Carrington downgrades Cintas (NASDAQ:CTAS) from Neutral to Sell and raises the price target from $530 ...
Stock split to increase accessibility to all investors, including Cintas employee-partners.Cintas Corporation (NASDAQ:CTAS), a ...